mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.3 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |